Blezer R, Fouache B, Willems G M, Lindhout T
Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.
J Biomed Mater Res. 1997 Oct;37(1):108-13. doi: 10.1002/(sici)1097-4636(199710)37:1<108::aid-jbm13>3.0.co;2-c.
It is hypothesized that immobilized heparin exerts a dual role in blood coagulation. On the one hand, the heparinized surface is because of its dense negative charge, thought to initiate the intrinsic pathway of blood coagulation. On the other hand, heparin is known as a potent anticoagulant drug. However, it remains to be seen how much contact-phase activation of factor XI contributes to thrombin formation and how this process is counterbalanced by which of the anti-protease activities of immobilized heparin. In the present study we examined the generation of factors XIa, IXa, and Xa, and thrombin in recalcified normal and antithrombin-depleted plasma exposed to polyacrylamide-graft polyurethane (PU) sheets modified by multipoint attachment of two different heparin species. One of them, HAH, contained the specific antithrombin binding sequence and the other one, NAH, had a low affinity for antithrombin and had no anticoagulant activity. Our data demonstrate that in contrast to PU, PU-NAH and PU-HAH are strong mediators of factor XIa and factor IXa formation in normal and antithrombin-deficient plasma. Interestingly, compared to PU-HAH and PU-NAH, thrombin formation was only slightly diminished in antithrombin-deficient plasma exposed to PU. In contrast, thrombin formation was dramatically delayed and diminished in normal plasma exposed to PU-HAH. These findings indicate that very low amounts of factor XIa apparently suffice to induce significant amounts of thrombin. In this sense, heparinized surfaces are highly thrombogenic, but our data also indicate that this activity is effectively counterbalanced by the anti-thrombin activity of the immobilized anti-coagulant species of heparin.
据推测,固定化肝素在血液凝固过程中发挥双重作用。一方面,肝素化表面由于其密集的负电荷,被认为会启动血液凝固的内源性途径。另一方面,肝素是一种强效抗凝药物。然而,目前尚不清楚因子XI的接触相激活对凝血酶形成的贡献程度,以及固定化肝素的哪种抗蛋白酶活性如何平衡这一过程。在本研究中,我们检测了在重新钙化的正常血浆和抗凝血酶缺乏的血浆中,暴露于通过两种不同肝素物种多点连接修饰的聚丙烯酰胺接枝聚氨酯(PU)片材后,因子XIa、IXa和Xa以及凝血酶的生成情况。其中一种肝素HAH含有特定的抗凝血酶结合序列,另一种肝素NAH与抗凝血酶的亲和力较低且无抗凝活性。我们的数据表明,与PU相比,PU-NAH和PU-HAH是正常血浆和抗凝血酶缺乏血浆中因子XIa和因子IXa形成的强介质。有趣的是,与PU-HAH和PU-NAH相比,暴露于PU的抗凝血酶缺乏血浆中的凝血酶形成仅略有减少。相反,暴露于PU-HAH的正常血浆中的凝血酶形成显著延迟且减少。这些发现表明,极少量的因子XIa显然足以诱导大量的凝血酶。从这个意义上说,肝素化表面具有高度血栓形成性,但我们的数据也表明,这种活性被固定化肝素抗凝物种的抗凝血酶活性有效地平衡了。